1. Product Overview
2. Research Methodology
3. Impact of COVID-19
on Middle East & Africa Active Pharmaceutical Ingredients Market
4. Executive Summary
5. Voice of Customer
6. Middle East &
Africa Active Pharmaceutical Ingredients Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value
6.2. Market Share &
Forecast
6.2.1. By Method of Synthesis (Biological v/s Synthetic)
6.2.2. By Source (Contact Manufacturing Organizations v/s
In-House Manufacturing)
6.2.3. By Therapeutic Application (Cardiovascular Diseases,
Anti-diabetic Drugs, Oncology Drugs, Neurological Disorders, Musculoskeletal
Disorders, Others)
6.2.4. By Molecule Type (Small v/s Large)
6.2.5. By Potency (Low v/s High)
6.2.6. By Drug Type (Innovator v/s Generics)
6.2.7. By Country
6.2.8. By Company (2021)
6.3. Product Market Map
7.
Saudi Arabia Active Pharmaceutical Ingredients Market
Outlook
7.1. Market Size &
Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Method of Synthesis
7.2.2. By Source
7.2.3. By Therapeutic Application
7.2.4. By Molecule Type
7.2.5. By Potency
7.2.6. By Drug Type
8.
UAE Active Pharmaceutical Ingredients Market Outlook
8.1. Market Size &
Forecast
8.1.1. By Value
8.2. Market Share &
Forecast
8.2.1. By Method of Synthesis
8.2.2. By Source
8.2.3. By Therapeutic Application
8.2.4. By Molecule Type
8.2.5. By Potency
8.2.6. By Drug Type
9.
Israel Active
Pharmaceutical Ingredients Market Outlook
9.1. Market Size &
Forecast
9.1.1. By Value
9.2. Market Share &
Forecast
9.2.1. By Method of Synthesis
9.2.2. By Source
9.2.3. By Therapeutic Application
9.2.4. By Molecule Type
9.2.5. By Potency
9.2.6. By Drug Type
10.
Kuwait Active Pharmaceutical Ingredients Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Method of Synthesis
10.2.2. By Source
10.2.3. By Therapeutic Application
10.2.4. By Molecule Type
10.2.5. By Potency
10.2.6. By Drug Type
11.
Bahrain Active Pharmaceutical Ingredients Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value
11.2.
Market Share & Forecast
11.2.1. By Method of Synthesis
11.2.2. By Source
11.2.3. By Therapeutic Application
11.2.4. By Molecule Type
11.2.5. By Potency
11.2.6. By Drug Type
12.
South Africa Active Pharmaceutical Ingredients Market
Outlook
12.1.
Market Size & Forecast
12.1.1. By Value
12.2.
Market Share & Forecast
12.2.1. By Method of Synthesis
12.2.2. By Source
12.2.3. By Therapeutic Application
12.2.4. By Molecule Type
12.2.5. By Potency
12.2.6. By Drug Type
13.
Nigeria Active Pharmaceutical Ingredients Market Outlook
13.1.
Market Size & Forecast
13.1.1. By Value
13.2.
Market Share & Forecast
13.2.1. By Method of Synthesis
13.2.2. By Source
13.2.3. By Therapeutic Application
13.2.4. By Molecule Type
13.2.5. By Potency
13.2.6. By Drug Type
14.
Egypt Active Pharmaceutical Ingredients Market Outlook
14.1.
Market Size & Forecast
14.1.1. By Value
14.2.
Market Share & Forecast
14.2.1. By Method of Synthesis
14.2.2. By Source
14.2.3. By Therapeutic Application
14.2.4. By Molecule Type
14.2.5. By Potency
14.2.6. By Drug Type
15.
Algeria Active Pharmaceutical Ingredients Market Outlook
15.1.
Market Size & Forecast
15.1.1. By Value
15.2.
Market Share & Forecast
15.2.1. By Method of Synthesis
15.2.2. By Source
15.2.3. By Therapeutic Application
15.2.4. By Molecule Type
15.2.5. By Potency
15.2.6. By Drug Type
16.
Morocco Active Pharmaceutical Ingredients Market Outlook
16.1.
Market Size & Forecast
16.1.1. By Value
16.2.
Market Share & Forecast
16.2.1. By Method of Synthesis
16.2.2. By Source
16.2.3. By Therapeutic Application
16.2.4. By Molecule Type
16.2.5. By Potency
16.2.6. By Drug Type
17. Market Dynamics
17.1.
Drivers
17.2.
Challenges
18. Market Trends &
Developments
19. Competitive
Landscape
19.1.
Competition Outlook
19.2.
Company Profiles (Includes SWOT Analysis)
19.2.1.
Teva Pharmaceutical Industries Ltd.
19.2.2.
Sun Pharmaceutical Industries Ltd.
19.2.3.
Pfizer Inc.
19.2.4.
Dr. Reddy's Laboratories Ltd.
19.2.5.
Cipla Inc.
19.2.6.
Neopharma LLC
19.2.7.
CAD Middle East Pharmaceutical Industries LLC
19.2.8.
KMK CHEMICALS FZ LLC
19.2.9.
Approcare Middle East
19.2.10.
AstraZeneca Plc.
19.2.11.
AbbVie Inc.
19.2.12.
Ketlaphela Pharmaceutical SOC Ltd
19.2.13.
Afriplex (Pty) Ltd
19.2.14.
Temad Co.
19.2.15.
Sanofi S.A.
20. Strategic
Recommendations